2025 AIChE Annual Meeting
(363a) Continuous Manufacturing Process Optimization and Scale-up: Three Step Reaction Telescope
Authors
Alexander Hesketh - Presenter, Rowan University
Joseph Imbrogno, Pfizer
Katharina Grohowalski, Pfizer Inc.
Anna Vicini, Pfizer
Kevin Girard, Bristol-Myers Squibb Company
Christina Meyer, University of Michigan
Michael St Pierre, Pfizer
Tomislav Ljubicic, Pfizer
Mark Telthorst, Pfizer
Jake Kneski, University of Connecticut
Job Seffernick, Pfizer
Jeff LaPointe, Pfizer
James Galloway, Pfizer
Kexin Ling, Pfizer
Courtney Talicska, Pfixer
Andrew Palm, Pfizer
Angel Diaz, Pfizer
Samuel Britner, Pfizer Inc.
Giuseppe Cogoni, Pfizer Inc.
Vicky Lange, Pfizer
Steven Guinness, Pfizer Inc.
Iain Gladwell, Pfizer
Gemma Scotney, Pfizer
A three-step telescoped continuous process has been designed and scaled up for the production of a drug substance intermediate. This work will describe the laboratory work completed to optimize the process and select equipment for commercial scale manufacturing. The selection of operating conditions was guided by Design of Experiments (DoEs) conducted in flow equipment at the laboratory scale using automated platforms and online analytical technologies. This data rich experimentation led to a quick determination of optimal reaction conditions and suitable operating ranges. Commercial equipment was chosen based on factors such as throughput, reactor geometry, and equipment capability. This telescoped process was successfully scaled up to commercial scale using modular equipment in a Good Manufacturing Practice (GMP) facility.